全自动深度学习CT肌少症评估:L1与L3椎体水平肌肉测量对不良临床结局的机会性预测比较
本研究回顾性纳入9223例无症状成人低剂量腹部CT,使用全自动深度学习工具在L1和L3水平测量肌肉衰减(肌脂肪变性)和肌肉面积(肌少症),比较预测髋部骨折和死亡的能力。结果显示L1与L3肌肉衰减测量预测性能无显著差异,且与FRAX和FRS临床风险评分相当或更优,而肌肉面积测量预测能力较弱。
要点
- L1水平肌肉衰减测量预测髋部骨折和死亡的能力与L3相当,可替代L3用于机会性筛查。
- 肌肉衰减测量预测性能与FRAX和FRS临床评分相当或更优,肌肉面积测量预测能力较弱。
- 使用L1水平可同时利用胸部和腹部CT进行肌少症评估,扩大机会性筛查范围。
诊断标准与关键数值
- 5年预测髋部骨折AUC:L1肌肉衰减0.717,L3肌肉衰减0.709,FRAX评分0.708。
- 5年预测死亡AUC:L1肌肉衰减0.737,L3肌肉衰减0.721,FRS评分0.688。
- 最低四分位风险比(HR)预测髋部骨折:L1衰减2.20,L3衰减2.45,FRAX评分2.53;预测死亡:L1衰减3.25,L3衰减3.58,FRS评分2.82。
- CT肌肉横截面积测量预测髋部骨折和死亡能力较弱(5年AUC≤0.571;HR≤1.56)。
临床应用与阅片要点
- 日常阅片可关注L1水平肌肉衰减(平均CT值),用于机会性评估肌少症及预测髋部骨折和死亡风险。
- 对于胸部或腹部CT,均可利用L1水平进行肌肉衰减测量,无需额外扫描。
- 肌肉横截面积测量预测价值有限,报告时可优先关注肌肉衰减指标。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 单中心研究,结果外推需谨慎。
- 仅纳入无症状成人,未包含有症状或高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Sarcopenia is associated with adverse clinical outcomes. CT-based skeletal muscle measurements for sarcopenia assessment are most commonly performed at the L3 vertebral level. OBJECTIVE. The purpose of this article is to compare the utility of fully automated deep learning CT-based muscle quantitation at the L1 versus L3 level for predicting future hip fractures and death. METHODS. This retrospective study included 9223 asymptomatic adults (mean age, 57 ± 8 [SD] years; 4071 men, 5152 women) who underwent unenhanced low-dose abdominal CT. A previously validated fully automated deep learning tool was used to assess muscle for myosteatosis (by mean attenuation) and myopenia (by cross-sectional area) at the L1 and L3 levels. Performance for predicting hip fractures and death was compared between L1 and L3 measures. Performance for predicting hip fractures and death was also evaluated using the established clinical risk scores from the fracture risk assessment tool (FRAX) and Framingham risk score (FRS), respectively. RESULTS. Median clinical follow-up interval after CT was 8.8 years (interquartile range, 5.1-11.6 years), yielding hip fractures and death in 219 (2.4%) and 549 (6.0%) patients, respectively. L1-level and L3-level muscle attenuation measurements were not different in 2-, 5-, or 10-year AUC for hip fracture (p = .18-.98) or death (p = .19-.95). For hip fracture, 5-year AUCs for L1-level muscle attenuation, L3-level muscle attenuation, and FRAX score were 0.717, 0.709, and 0.708, respectively. For death, 5-year AUCs for L1-level muscle attenuation, L3-level muscle attenuation, and FRS were 0.737, 0.721, and 0.688, respectively. Lowest quartile hazard ratios (HRs) for hip fracture were 2.20 (L1 attenuation), 2.45 (L3 attenuation), and 2.53 (FRAX score), and for death were 3.25 (L1 attenuation), 3.58 (L3 attenuation), and 2.82 (FRS). CT-based muscle cross-sectional area measurements at L1 and L3 were less predictive for hip fracture and death (5-year AUC ≤ 0.571; HR ≤ 1.56). CONCLUSION. Automated CT-based measurements of muscle attenuation for myosteatosis at the L1 level compare favorably with previously established L3-level measurements and clinical risk scores for predicting hip fracture and death. Assessment for myopenia was less predictive of outcomes at both levels. CLINICAL IMPACT. Alternative use of the L1 rather than L3 level for CT-based muscle measurements allows sarcopenia assessment using both chest and abdominal CT scans, greatly increasing the potential yield of opportunistic CT screening.
引用
- Pickhardt PJ, Perez AA, Garrett JW, et al. Fully Automated Deep Learning Tool for Sarcopenia Assessment on CT: L1 Versus L3 Vertebral Level Muscle Measurements for Opportunistic Prediction of Adverse Clinical Outcomes. AJR Am J Roentgenol. 2021. PMID: 34406056. doi:10.2214/AJR.21.26486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。